<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1608462</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2025.1608462</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Highlights from conference of Biomaterials International 2023</article-title>
<alt-title alt-title-type="left-running-head">Liu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2025.1608462">10.3389/fbioe.2025.1608462</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Shih-Jung</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1823811/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanawa</surname>
<given-names>Takao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/628374/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sosnik</surname>
<given-names>Alejandro</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/120327/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Mechanical Engineering</institution>, <institution>Chang Gung University</institution>, <addr-line>Taoyuan</addr-line>, <country>Taiwan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Biomaterials and Bioengineering</institution>, <institution>Tokyo Medical and Dental University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Materials Science and Engineering</institution>, <institution>Technion Israel Institute of Technology</institution>, <addr-line>Haifa</addr-line>, <addr-line>Haifa</addr-line>, <country>Israel</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1500489/overview">Candan Tamerler</ext-link>, University of Kansas, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Shih-Jung Liu, <email>shihjung@mail.cgu.edu.tw</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>05</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1608462</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Liu, Hanawa and Sosnik.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Hanawa and Sosnik</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Bioeng. Biotechnol." xlink:href="https://www.frontiersin.org/research-topics/55139" ext-link-type="uri">Editorial on the Research Topic <article-title>Highlights from conference of Biomaterials International 2023</article-title>
</related-article>
<kwd-group>
<kwd>biomaterials</kwd>
<kwd>tissue engineering</kwd>
<kwd>drug delivery</kwd>
<kwd>surface modification</kwd>
<kwd>biomechanics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Biomaterials</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The Biomaterials International 2023 Conference served as a pivotal forum for the global biomaterials community, bringing together researchers, clinicians, and industry experts to share groundbreaking advancements and foster collaborative efforts. Hosted in Sapporo, Japan, from July 30 to 3 August 2023, and organized by Chang Gung University and Tokyo Medical and Dental University, the conference underscored the interdisciplinary nature and rapid evolution of biomaterials science.</p>
<p>This special Research Topic, <italic>&#x201c;Highlights from Conference of Biomaterials International 2023,&#x201d;</italic> curates a selection of eight exemplary articles that encapsulate the innovative spirit and scientific rigor presented at the conference. These contributions span a diverse array of topics, reflecting the multifaceted landscape of biomaterials research.</p>
</sec>
<sec id="s2">
<title>Decellularized tissue for soft-hard interface regeneration</title>
<p>Decellularized tissue, composed of extracellular matrix stripped of cellular components, offers a promising scaffold for tissue regeneration. Clinically, it has been used in various forms, including dermal and intestinal matrices, as prosthetic and covering materials. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2025.1394714">Suzuki et al.</ext-link> provides a review to explore how these tissues can support <italic>in situ</italic> regeneration by mimicking the structural and mechanical gradients of native tissue interfaces.</p>
</sec>
<sec id="s3">
<title>Advancements in biomaterials for cancer therapeutics</title>
<p>One notable review explores the application of metal-organic frameworks (MOFs) in next-generation cancer treatments (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1397804">Shano et al.</ext-link>). By adopting a biophysical perspective, the authors elucidate how MOFs can enhance drug delivery and efficacy, offering promising avenues for oncological interventions.</p>
</sec>
<sec id="s4">
<title>pH-dependent control of carbonate apatite for artificial bone design</title>
<p>The success of artificial bone materials relies heavily on both their composition and internal architecture. In the study of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1396275">Wang et al.</ext-link>, carbonate apatite (CAp), a bone-like mineral, was synthesized from calcium carbonate under varying pH conditions to investigate how pH influences the resulting material. Advanced characterization techniques revealed that lower pH levels accelerated the transformation to CAp and altered its microstructure and degradation behavior.</p>
</sec>
<sec id="s5">
<title>Innovations in implant surface modifications</title>
<p>The development of novel implant surfaces is critical for improving biocompatibility and integration. Research featured in this Research Topic investigates the use of phosphorylated pullulan for implant surface modification (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1378039">Nagamoto et al.</ext-link>), demonstrating enhanced osteoconductivity and potential for improved clinical outcomes.</p>
</sec>
<sec id="s6">
<title>Advances in biomedical alloys</title>
<p>The mechanical properties and biocompatibility of titanium-molybdenum (Ti-Mo) alloys are further enhanced through oxygen addition, as detailed in one of the original research articles (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1380503">Kobayashi and Okano</ext-link>). This modification results in improved microstructure and mechanical performance, making Ti-Mo alloys more suitable for biomedical applications.</p>
</sec>
<sec id="s7">
<title>Biomechanical insights into spinal surgery</title>
<p>A comparative biomechanical study examines the influence of various pilot hole profiles on pedicle screw fixation strength in both minimally invasive and traditional spinal surgeries (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2024.1359883">Li et al.</ext-link>). The findings provide valuable insights that could inform surgical techniques and improve patient outcomes.</p>
</sec>
<sec id="s8">
<title>Deep learning for cranial implant design</title>
<p>The integration of deep learning techniques in biomedical engineering is exemplified by research on creating high-resolution 3D cranial implant geometries (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1297933">Wu et al.</ext-link>). This approach streamlines the design process, offering personalized solutions for cranial reconstruction.</p>
</sec>
<sec id="s9">
<title>Targeted drug delivery for lung cancer</title>
<p>An innovative study focuses on modified gefitinib-conjugated Fe<sub>3</sub>O<sub>4</sub> nanoparticles for enhanced drug delivery in non-small cell lung cancer treatment (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1272492">Thangudu et al.</ext-link>). The research provides an image-guided mechanistic analysis of tumor uptake, highlighting the potential for more effective and targeted therapies.</p>
<p>Collectively, these articles not only showcase the depth and breadth of research presented at Biomaterials International 2023 but also highlight the ongoing commitment of the biomaterials community to address complex healthcare challenges through innovative science and technology.</p>
<p>We extend our gratitude to all authors, reviewers, and conference organizers for their invaluable contributions to this Research Topic. It is our hope that this Research Topic serves as a catalyst for further discoveries and collaborations in the dynamic field of biomaterials.</p>
<p>For a comprehensive exploration of these studies, readers are encouraged to access the full articles available in this Research Topic.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s10">
<title>Author contributions</title>
<p>S-JL: Writing &#x2013; review and editing. TH: Writing &#x2013; review and editing. AS: Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s11">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Ministry of Science and Technology, Taiwan (Contract No. 111-2221-E-182-005-MY2) and Chang Gung Memorial Hospital (Contract No. CMRPD2P0071) for S-JL. AS thanks the support of the Tamara and Harry Handelsman Academic Chair.</p>
</sec>
<sec sec-type="COI-statement" id="s12">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s13">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s14">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>